Our investigation of GABA, pharmacology yielded data in agreement with previously reported results. We have described a parasagittal pattern of GABA, binding in the cerebellar molecular layer and assigned the majority of cerebellar GABA, binding sites to Purkinje cell dendrites. Finally, development studies reveal transient peaks in GABA, binding in the cerebellar molecular layer and deep cerebellar nuclei.
Two distinct types of receptors mediate synaptic transmission by the inhibitory amino acid neurotransmitter GABA in the central nervous system.7,9"1*32*3*.53 The bicuculline-sensitive GABA, receptor is part of a chloride ionophore and has additional modulatory sites for benzodiazepines and other compounds.36*70*82 The bicuculline-insensitive GABAB receptor is linked to guanosine triphosphate binding proteins5*28*29*33*".56*9'*B and is activated by the selective GABA, receptor agonist baclofen.7-9x38 GABAa receptors are located both pre-933,48*87,88 and post-synaptically,"~73~77~79 as well as on glial cell~.~' Neuronal GABA, receptor activation can either inhibit Ca2+ currents29,31,%,63.91.100 or activate K+ cur-*To whom correspondence should be addressed at: Neuroscience Laboratory Building, 1103 E. Huron, Ann Arbor, MI 48104-1687, U.S.A. A&euiations: DCN, deep cerebellar nuclei; EAA; excitatory amino acid; GDP-B-S; guanosine S-O-(2-thiodiphosphate); GMP; guanosine 5'-monophosphate; GTP-y-S; guanosine S-0-(3-thiotriphosphate); MAM; methyl azoxymethanol; P; postnatal day; Pep-2; Purkinje cell protein 2; St/+; heterozygous stumbler mice; st/st; homozygous stumbler mice; 3-AP; 3-acerylpyridine;
3-APA; 3-aminopropylphosphonous acid.
rents 5,4'~80,86,90 depending on the cellular localization of th; receptor. GABA, receptor agonists can act through second messenger systems to inhibit basal or forskolin-stimulated cyclic AMP formation,52,95,97,98 potentiate cyclic AMP formation induced by other neurotransmitters,52.6'.9).95,99 or modulate histamine and serotonin stimulated inositol phospholipid turnover. 20 .45 Depending on the brain region examined, GABA, receptor activation can decrease neurotransmitter release,9 hyperpolarize postsynaptic neurons, 19,73,77m79 or act presynaptically to inhibit inhibitory neurons. 23,73.74 While the functional roles of the GABA, receptor are not fully understood, the GABA, receptor may be involved in the formation of hippocampal long term potentiation,".75.76.8' antidepressant action,59,67,93 nociception,4,88 epilepsy,14v74 modulation of neocortical receptor fields, 35 and regulation of thalamic neuronal activity.* ' We chose to study GABA, receptors in the cerebellum because the neuroanatomy of the cerebellum is well understood and GABA mediates much of the neural processing within the cerebellum as well as cerebellar cortical output via Purkinje cells. The molecular layer of the cerebellum possesses the second highest density of GABA, binding sites within the central nervous system.'1*'8*96 The cellular localiz-ation of GABA, binding within the molecular layer has not been conclusively established as previous attempts to examine this question have produced conflicting results.'".h2.Yx Moreover, GABA, binding in the molecular layer of the cerebellum follows a pattern of parasagittal zones of alternating high and low density [3H]GABA binding.' This study will examine four aspects of GABA, binding in the cerebellum. We will investigate both the pattern of parasagittal zonation and the cellular localization of GABA, binding within the molecular layer. We will also describe both the pharmacological characteristics and the postnatal development of GABA, binding in the rat cerebellum. Seven granuloprival rats were produced by injecting male rat pups-with methyl azoxymethanol (MAM, 30 mg/kg. diluted to 10 ma/ml in 0.9% NaCl. in) on P I. Methyl azoxymethanol iz a nucleic acid alkylatmg agent which kills cells undergoing mitosis at the time of drug administration. When administered on P 1, MAM destroys predominantly granule cells and cerebellar interneurons.s"~60 While MAM does not reduce the number of Purkinje cells,17 the position of these cells and the orientation and extent of their dendritic arbor may be altered."
Six saline injected littermates served as controls. Animals were killed at P 40.
The climbing fiber input to the cerebellum was destroyed in a third group of animals by destroying the inferior olive with 3-acetylpyridine (3-AP) as described by Llinas." Six adult rats were injected with 3-AP (75 mg/kg, i.p.). an antimetabolite which destroys the inferior olivary nucleus,26.27,66 followed 3 h later by an injection of harmaline (15 mg/kg, i.p.), which causes olivary neurons to fire rapidly, making them more susceptible to 3-AP toxicity.2S.65 3-AP toxicity was then stopped by an injection of nicotinamide (300 mg/kg, i.p.) 90 min after harmaline treatment.s'.9z All 3-AP treated animals developed an ataxic gait. Controls were six saline injected animals. Animals were killed six days following treatment.
Development studies. Pregnant Sprague-Dawley rats were purchased from Harlan Industries (Indianapolis, IN) and male pups were killed at P 1 (n = 6) P 3 (n = 6). P 7 (n = 6) P14(n=lI),P21(n=2l),andP2X(n=ll).Samplesizes tn older animals were expanded to mclude a wader range 01 anterior to posterior levels, In a separate experiment. binding was compared in three P 28 rdtS and three adult rats (175 195g: P 42). Bands of greater and lesser optical density comprising the pattern of parasagittal zonation were visually identified and analysed to determine the extent of parasagittal zonation. Photographs were made from the original films and traced onto paper to reconstruct the pattern of parasagittal zonation.
Tissue preparation
Localization studies. Binding to the molecular and internal granule cell layer of animals in st/st mutant mice, MAM treated rats, and 3-AP treated rats was compared to binding in the respective control groups. Data from experimental and control groups were compared using a Student's t-test. Histological analysis of sections from each treatment group was performed on tissue sections hxed over paraformaldehyde vapor and stained with 0.5% Cresyl Violet to ascertain thh the lesion treatment had been effective.
Developmental studies. In the first experiment, GABA, binding in the deep cerebellar nuclei (DCN) and cerebellar cortex was determined in P 1 rats and in the internal granule cell layer, molecular layer, lateral DCN, and medial DCN of P 3, P 7, P 14, P 21, and P 28 rats. In the molecular layer of P 14, P 21, and P 28 rats, total GABA, binding was determined by averaging optical density readings taken throughout the molecular layer. In a separate analysis, GABA, binding in the inner molecular layer was determined by sampling the inner third of the molecular layer, near the Purkinje cell layer, and binding in the outer molecular layer was determined by sampling the outer third of the molecular layer, near the external granule cell layer. In addition, readings were taken at P 21 and P 28 of the bands of greater and lesser optical density comprising the pattern of parasagittal zonation within the molecular layer.
In the second experiment, GABA, binding was compared in the granule cell layer and the molecular layer in P 28 and 
RESULTS

Pharmacology
The rank order of potency for displacing [3H]GABA from GABA, binding sites in the molecular layer was 3-APA >>Zhydroxysaclofen = CGP 35348 > phaclofen (Fig. 1A) . GTP-7-S and GDP-/I-S decreased the affinity of [3H]GABA for GABA, sites in the molecular layer with 50% decreases in binding in the nanomolar range while GMP and ATP did not decrease binding by 50% at concentrations up to 100pM (Fig. 1B) . The IC,,'s and K,'s for all pharmacology experiments are reported in Table 1 . Cerebellar GABA, receptors 31.5 parasagittal zones of high binding did not differ significantly from overall binding in the molecular layer. This pattern was found in the posterior vermis, with five bands of high GABA, binding in posterior lobule VII and anterior lobule VII, four bands in posterior lobule VIII and anterior lobule IX, and three bands in posterior lobule IX and anterior lobule X (Fig. 3) . In addition to this parasagittal binding pattern, an anterior to posterior gradient in overall binding levels was observed in the molecular layer in horizontal sections. Binding posterior to the primary fissure averaged 572 f 24 fmoles/mg protein while binding anterior to the fissure averaged 406 f 14 fmoles/mg protein (n = 4, P < 0.01, paired t-test). No differences were found between control and experimental groups for GABA, binding levels in the internal granule cell layer (data not shown); however, the low level of GABA, binding sites in the internal granule cell layer makes GABA, binding an insensitive measure of changes in the internal granule cell layer. Histology revealed that MAM animals had the gyrated folia typical of MAM treated animal? and that 3-AP treated animals had profound loss of inferior olive neurons.
Development of GABA, binding in rut cerebellum
Deep cerebellar nuclei. GABA, binding in the DCN was transient (Figs 6 and 7) . Binding levels peaked at P 3 with an average value of 833.3 fmoles/mg protein and gradually decreased to adult levels by P 21. Binding in the medial DCN decreased more rapidly with maturity than in the lateral DCN. Paired t-tests revealed that this difference was significant at P 3 (P < 0.05), P 7 (P < O.OOOl), P 14 (P < O.OOl), and P 21 (P < 0.005 within the molecular layer at P I4 and P 21. GABA, binding in the inner molecular layer was 79 :t. I "A higher than binding in the outer molecular layer at I' I4 and 13 + 1% higher in the inner molecular layer than in the outer molecular layer at P 21 (P > 0.00 I. two-tailed paired t-test; Fig. 8 ). In P 28 and adult (P 42) animals there was no difference in GABA, binding between the inner and outer molecular layer. Parasagittal zonation of GABA, binding was not visible at P I, P 3, P 7. or P 14. By P 21. parasagittal zonation could be detected (Fig. 8) and the magnitude of the difference between the zones of low GABA, binding and those of high binding increased with maturity. At P 21 and P 28, binding in zones of lower binding was 19% and 25% lower, respectively. than in zones of higher binding. Results from the mapping study revealed that in adults, binding in low binding zones was 37% lower than in higher binding zones (see above). The presence of lower binding zones at P 21 and P 28 does not decrease overall binding levels in the molecular layer because these bands comprise a fraction of the entire molecular layer.
Internal granule cell layer. Binding to the GABA, site in the internal granule cell layer was also discernable by P 3, peaked between P 14 and P 28 (Figs 6, 7) and then declined 48% (P < 0.05, two-tailed t-test) by adulthood (P 42).
DISCUSSION
Pharmacological characteristics of GABA, binding in rat brain
The rank order of potency of agonists and antagonists observed in this study concur with previously reported values in homogenate and functional studies.6.30 Differences in the absolute values of K,'s reported in this study as compared to others may be due to differences in technique. For example, autoradiography preparations cannot be washed as thoroughly as homogenate preparations, preventing the complete removal of endogenous GABA. Endogenous GABA will complete with the labeled ligand and alter K, values. However, despite these discrepancies, the rank order of potency of these ligands as well as the approximate differences in magnitude between K,'s are the same as those previously reported in homogenate studies. In addition, the guanyl nucleotide analogues GTP-y -S and GDP-/?-S potently decreased GABA, binding while GMP and ATP did not. The inhibition of GABA, binding by GTP-y-S and GDP-/f-S is consistent with a G-protein coupled receptor.
Our On the other hand, parasagittal GABA, binding site zones may only label a subset of the parasagittal zones identified with other markers. Further studies will be necessary to clarify the relationship between GABA, parasagittal zonation and other anatomic markers of parasagittal zonation.
Cerebellar cortical functions may also be organized into parasagittal zones. Electrophysiological studies have demonstrated that cerebellar Purkinje cells can be divided into distinct parasagittal groups ditferentiated by their response properties to peripheral stimulation and the pattern of distribution of spino-olivocerebellar afferents.39.40 The GABA, agonist baclofen will inhibit neuronal activity when iontophoretically applied to Purkinje cells.2' In addition to parasagittal zonation, GABA, binding in the cerebellar molecular layer is also characterized by an increasing anterior to posterior gradient of GABA, binding. Both aspects of heterogeneous GABA, receptor distribution could influence the physiological properties of Purkinje cells.
Cellular localization of GABA, binding in the moleeular layer qf the cerebellum
We have combined analysis of three lesion groups to determine the probable cellular localization of GABA, binding sites within the molecular layer of adult rodent cerebeliar cortex. Previous localization studies have yieided convicting results.i0,62,q8 It has been suggested that molecular layer GABA, binding sites may be located on parallel fibers,98 on the terminals of climbing fibers,62 or on cerebellar Purkinje cell dendrites. lo Our data support the conclusion that the majority of GABA, binding sites are located on Purkinje cell dendrites. Neither 3-AP treatment, which destroys the olivocerebellar climbing fibers, nor MAM treatment, which predominantly depletes granule, stellate, and basket cell~,~~~~ produced a significant decrease in [3H]GABA binding to GABA, sites in the molecular layer of the cerebellum. Stumbler mutant mice, however, known to have decreased numbers of both granule cells and Purkinje cells as well as immature Purkinje cell dendritic arbors, displayed significantly less GABA, binding in the molecular layer than controls.
While this type of lesion analysis must be interpreted cautiously because secondary changes occur in neuronal populations spared by the toxic or genetic lesion, '3~17*89 lesion and mutant studies are a historically useful method for determining the cellular localization of neurotransmitter binding sites in the cerebellum.46*50*68*83 The decrease in GABA, binding in homozygote stumbler mutant mice could be due to either decreased parallel fibers or Purkinje cell dendrites.
The absence of decreased GABA, binding in MAN treated rats, whose primary deficiency is in the granule cell population, however, suggests that the majority of GABA, binding sites detected by our assay are not located on the parallel fibers. Our conclusions assume identical neuronal distribution of GABA, binding in the cerebella of rats and mice.
Our suggestion that GABA, receptors are located on Purkinje cell dendrites. is supported by other data. Bowery et al. examined several strains of mutant mice with primary deficits in different neuronai populations to conclude that GABA, receptors are located primarily on Purkinje cell dendrites.'* In addition, electrophysiological studies have revealed that iontophoretically applied baclofen inhibits Purkinje cell activity.** The discrepancy between our findings and previous results may be due to the different methods used to measure GABA, receptors in the previous studies. Kato et al. measured rH]baclofen binding in homogenate preparations and reported decreases in GABA, binding followed 3-AP treatmenta Wojcik et al. cited decreases in GABA, receptor-mediated inhibition of adenylate cyclase activity in Weaver mutant mice as evidence for concluding that GABA, receptors were located on parallel fibers.98 While the Weaver mice are deficient in granule cells, they are also secondarily deficient in Purkinje cell dendrites,89 which could be the source of the observed reduction in GABA, activity. However, Wojcik et al. also reported the absence of any reduction of GABAs receptor-mediated inhibition of adenylate cyclase activity in Nervous mutant mice which are deficient in Purkinje ~ells.~* While the results obtained by Wojcik et aI.% do not concur with our findings, this may be due to either the indirect method of assessing the presence of GABA, receptors in the previous study or to the presence of presynaptic GABA, binding sites which our experiments were unable to detect. It has been shown that the great majority of cerebellar molecular layer adenylate cyclase is localized in the parallel fibers." the localization of adenylate cyclase to granule cell terminals suggests that GABA, receptor-mediated inhibition of adenylate cyclase might be a sensitive measure when used to detect GABAa receptors on granule cell terminals but would not be particularly sensitive to changes in GABA, receptors on Purkinje cells. Another possible source of variance between our results and those of Wojcik et ~1.~~ is the shrinkage of the molecular layer in MAM treated rats. Shrinkage could obscure decreases in GABAk binding in the NAM treated group which might result from the presence of presynaptic GABA, receptors on parallel fibers. Shrinkage will also cause underestimation of the decreases in binding in st/st mutant mice.
Recent immunohistochemical studies with an antibody to L-baclofen indicate that GABA, receptors in the cerebellar molecular layer are found on both Purkinje cell dendrites and parallel fibers.69 The immunohistochemical data, combined with previous evidence for GABA, receptor localization on both Purkinje cells and parallel fibers, suggest that cerebellar molecular layer GABA, receptors are located on both cell types. However, our data indicate that most cerebellar molecular layer GABAa binding sites detected by [3H]GABA autoradiography are located on Purkinje cell dendrites.
development of GABA, banking in the cerebeiIum
The most striking feature of cerebellar GABA, binding site development is a robust transient expression of GABA, binding in the deep cerebellar nuclei. This binding did not completely decrease to adult levels until P 21. This developmental decrease in binding levels could theoretically result from decreased tritium emissions in adult animals due to increased myelination of the deep cerebellar white matter. Tritium emissions are absorbed to a greater degree by white matter than gray matter."" If tritium "quenching" due to increased myelination were a factor in the postnatal decrease in DCN GABA, binding, then binding assays using [14C]GABA in adults should reveal increased DCN GABA, binding when compared with ['H]GABA binding studies. Such an increase was not observed and white matter quenching cannot be the cause of transient GABAa binding in the DCN.
Our data also indicate that GABA, binding peaks between P 14 and P 28 in the molecular layer before h M. TWKWJN and R. L. ALBI~ decreasing to adult levels. This result is interesting as neurogenesis and the formation of synaptic connections within the molecular layer is ongoing between P 14 and P 28. In addition, previous studies have indicated that neither GABA, nor excitatory amino acid (EAA) binding sites in the cerebellar cortex reach adult levels until around P 20 or later.4',84 While overall binding in the molecular layer peaked by P 14, a developmentally immature pattern of binding is present. GABA, binding in the lower molecular layer (adjacent to the Purkinje cell layer) is significantly higher than binding in the upper molecular layer (subjacent to the external granule cell layer) in P 14 and P 21 animals. While we cannot be sure of the neuronal localization or function of these GABA, binding sites in immature animals, this gradient of binding in the molecular layer parallels both the formation of basket and stellate cells in the molecular layer and the appearance of synaptic contacts between parallel fibers and Purkinje cell dendrites. Basket cells are first seen around day 667 in the lower molecular layer. Newly formed basket and stellate cells are then stacked from the bottom of the molecular layer (our inner molecular layer) upward, with mature stellate cells appearing at day 21 and later.' Synaptogenesis between parallel fibers and Purkinje cell dendrites also follows a progression from the bottom of the molecular layer upwards. In day 15 animals, synapses are beginning to form in the lower part of the molecular layer. By day 21, the Purkinje cells appear mature, but parallel fiber synapses have yet to be formed in the upper molecular layer. Finally, the upward progression of synaptogenesis seems to be complete by 30 days.' However, while GABA, binding is greater in the bottom of the molecular layer at days 14 and 2 1, there is substantial GABA, binding in the upper molecular layer.
The pattern of parasagittal zonation is not visible at P 14, begins to appear at P 21, and resembles mature patterns by P 28. 
CONCLUSION
The pharmacology and distribution of GABA, binding sites in the cerebellum are in agreement with previously reported studies. The observation of a parasagittal zonation pattern in the molecular layer has been confirmed. This pattern is characterized by five bands of higher binding in the molecular layer of the vermis in the posterior lobule VII and anterior lobule VIII, four bands in posterior lobule VIII and anterior lobule IX, and three bands in posterior lobule IX and anterior lobule X and may be a subset of previously defined markers of cerebellar cortical zonation.
An anterior to posterior gradient of increasing GABA, binding was also noted. Localization studies indicate that the majority of the cerebellar molecular layer GABA, binding sites detected with our assay are located on Purkinje cell dendrites.
Developmental studies indicate that GABA, binding in the molecular and granular cell layer of the cerebellum peaks between P 14 and P 28 and then decreases to adult levels. Transient expression of GABA, binding sites in the deep cerebellar nuclei which decreases to adult levels by P 21 was also observed. Further studies are needed to address the functional nature of these GABA, binding sites at different stages of development.
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